In vitro and in vivo experiments revealed that elevated level of miR-942 in TRAIL-resistant cells or aggressive cancer tissues correlates with ISG12a downregulation, suggesting that miR-942 might be a causal factor in the downregulation of ISG12a in cancers. The gene discussed is IFI27; the disease is cancer.